Vanguard Global Advisers
KMTS

Vanguard Global Advisers’s Kestra Medical Technologies KMTS Stock Holding History

Vanguard Global Advisers’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Sell
7,235
-2,533
-26% -$53K ﹤0.01% 2530
2026
Q1 		$195K Buy
+9,768
New +$230K ﹤0.01% 2451

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Global Advisers's KMTS Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Kestra Medical Technologies (KMTS) stake by 26% in Q2 2026, selling an estimated $53K and leaving 7,235 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #2530.

Vanguard Global Advisers first reported a position in KMTS in Q1 2026 and has held it in 2 quarters since. The position peaked at $195K in Q1 2026. 109 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Vanguard Global Advisers held 7,235 shares of Kestra Medical Technologies worth $184K as of Q2 2026.
  • Vanguard Global Advisers sold 2,533 Kestra Medical Technologies shares in Q2 2026, an estimated $53K.
  • Kestra Medical Technologies made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2530 holding.
  • Vanguard Global Advisers first reported a position in Kestra Medical Technologies in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Kestra Medical Technologies position peaked at $195K in Q1 2026.
  • 109 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.